Voyager Therapeutics Inc — Cash Flow (NASDAQ:VYGR) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 96.72 M53.52 M12.51 M77.92 M15.31 M 116.73 M Cash from investing activities 113 M65.91 M7.34 M141.64 M94.86 M 50.82 M Cash from financing activities 3.16 M612 K1.11 M33.65 M114.02 M 1.25 M Free cash flow 84.62 M51.92 M10.02 M74.66 M11.79 M 114.61 M

Notícias

Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates

Alzheimer's Clinical Trial Results, Sadly Running True To Form

J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline - Johnson & Johnson (NYSE:JNJ)

Preço-alvo das ações da Voyager Therapeutics reduzido para US$ 25 pela H.C. Wainwright

Voyager Therapeutics stock price target lowered to $25 at H.C. Wainwright

Voyager Therapeutics na Conferência Stifel: Inovações neuroterapêuticas

Voyager Therapeutics at Stifel Conference: Neurotherapeutic Innovations

Leerink Partners eleva preço-alvo das ações da Voyager Therapeutics para US$ 12

Voyager Therapeutics stock price target raised to $12 by Leerink Partners

Lucro da Voyager Therapeutics Inc superou projeções por $0,05; receita supera estimativas

Voyager Therapeutics Inc earnings beat by $0.05, revenue topped estimates

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates